Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 1032 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact1032 DOIs

DOIs for this ISSN

Showing the top 5 of 10000 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Current FDA-Approved Therapies for High-Grade Malignant Glio… (10.3390/biomedicines9030324)	ORCID	61.22	280
2	Meningioma: A Review of Epidemiology, Pathology, Diagnosis,… (10.3390/biomedicines9030319)	ORCID	60.58	264
3	Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing S… (10.3390/biomedicines8030050)	ORCID	57.69	202
4	Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Fema… (10.3390/biomedicines7010005)	ORCID	57.63	201
5	The Challenges and Strategies of Antisense Oligonucleotide D… (10.3390/biomedicines9040433)	ORCID	57.31	195
6	Product-Related Impurities in Clinical-Grade Recombinant AAV… (10.3390/biomedicines2010080)	ORCID	57.14	192
7	Evidence for the Involvement of the Master Transcription Fac… (10.3390/biomedicines6030082)	ORCID	56.80	186
8	Hypoxia, Metabolism and Immune Cell Function (10.3390/biomedicines6020056)	ORCID	55.76	169
9	Modulation of Intracellular Copper Levels as the Mechanism o… (10.3390/biomedicines9080852)	ORCID	55.03	158
10	Cell-Penetrating Peptides to Enhance Delivery of Oligonucleo… (10.3390/biomedicines6020051)	ORCID	54.55	151
11	BET Family Protein BRD4: An Emerging Actor in NFκB Signaling… (10.3390/biomedicines6010016)	ORCID	53.96	143
12	NF-κB: A Double-Edged Sword Controlling Inflammation (10.3390/biomedicines10061250)	ORCID	53.18	133
13	Biomarkers and Utility of the Antioxidant Potential of Probi… (10.3390/biomedicines9101340)	ORCID	52.51	125
14	Tripartite Combination of Candidate Pandemic Mitigation Agen… (10.3390/biomedicines8050129)	ORCID	52.25	122
15	Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndrome… (10.3390/biomedicines7020042)	ORCID	51.70	116
16	Relapsing Polychondritis: An Updated Review (10.3390/biomedicines6030084)	ORCID	51.42	113
17	CD64: An Attractive Immunotherapeutic Target for M1-type Mac… (10.3390/biomedicines5030056)	ORCID	51.23	111
18	Laboratory Monitoring of Direct Oral Anticoagulants (DOACs) (10.3390/biomedicines9050445)	ORCID	51.13	110
19	Update on Treatment Guideline in Fibromyalgia Syndrome with… (10.3390/biomedicines5020020)	ORCID	50.94	108
20	NF-κB Signalling in Glioblastoma (10.3390/biomedicines5020029)	ORCID	50.73	106
21	Site-Specific Antibody Conjugation for ADC and Beyond (10.3390/biomedicines5040064)	ORCID	50.00	99
22	Inflammation, Anxiety, and Stress in Attention-Deficit/Hyper… (10.3390/biomedicines9101313)	ORCID	49.33	93
23	Overview of Acute Ischemic Stroke Evaluation and Management (10.3390/biomedicines9101486)	ORCID	49.33	93
24	Blood Neurofilament Light Chain: The Neurologist’s Troponin? (10.3390/biomedicines8110523)	ORCID	48.98	90
25	Aptamer-siRNA Chimeras: Discovery, Progress, and Future Pros… (10.3390/biomedicines5030045)	ORCID	48.86	89
26	Involvement of STAT5 in Oncogenesis (10.3390/biomedicines8090316)	ORCID	48.86	89
27	20-Hydroxyecdysone, from Plant Extracts to Clinical Use: The… (10.3390/biomedicines9050492)	ORCID	47.85	81
28	Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at th… (10.3390/biomedicines12071386)	References ORCID	47.71	8
29	Is a High HDL-Cholesterol Level Always Beneficial? (10.3390/biomedicines9091083)	ORCID	47.71	80
30	Extracellular Vesicles Derived from Kefir Grain Lactobacillu… (10.3390/biomedicines8110522)	ORCID	47.58	79
31	c-Met and Other Cell Surface Molecules: Interaction, Activa… (10.3390/biomedicines3010046)	ORCID	47.16	76
32	Combination Strategies of Different Antimicrobials: An Effic… (10.3390/biomedicines10092219)	ORCID	47.02	75
33	Recent Innovations in Peptide Based Targeted Drug Delivery t… (10.3390/biomedicines4020011)	ORCID	46.88	74
34	Pathogens and Their Effect on Exosome Biogenesis and Composi… (10.3390/biomedicines6030079)	ORCID	46.73	73
35	Effect of Clostridium butyricum on Gastrointestinal Infectio… (10.3390/biomedicines10020483)	ORCID	46.58	72
36	Inflammation in Duchenne Muscular Dystrophy–Exploring the Ro… (10.3390/biomedicines9101366)	ORCID	46.58	72
37	Aptamer Cell-Based Selection: Overview and Advances (10.3390/biomedicines5030049)	ORCID	46.28	70
38	Macrophages and Iron: A Special Relationship (10.3390/biomedicines9111585)	ORCID	46.13	69
39	Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastom… (10.3390/biomedicines10030564)	ORCID	45.65	66
40	Amino Acid Metabolites Associated with Chronic Kidney Diseas… (10.3390/biomedicines8070222)	ORCID	45.32	64
41	Applications of Plasma-Activated Liquid in the Medical Field (10.3390/biomedicines9111700)	ORCID	45.15	63
42	Detecting Early Cognitive Decline in Alzheimer’s Disease wit… (10.3390/biomedicines11020355)	ORCID	44.98	62
43	Tumor Restrictions to Oncolytic Virus (10.3390/biomedicines2020163)	ORCID	44.81	61
44	The Chemistry, Pharmacology and Therapeutic Potential of the… (10.3390/biomedicines7040098)	ORCID	44.81	61
45	Tuning the Degradation Rate of Alginate-Based Bioinks for Bi… (10.3390/biomedicines10071621)	ORCID	44.63	60
46	Preoperative Localization for Primary Hyperparathyroidism: A… (10.3390/biomedicines9040390)	ORCID	44.63	60
47	Noncanonical NF-κB in Cancer (10.3390/biomedicines6020066)	ORCID	44.45	59
48	Stem Cell Banking for Regenerative and Personalized Medicine (10.3390/biomedicines2010050)	ORCID	44.09	57
49	From Benchtop to Bedside: A Review of Oncolytic Virotherapy (10.3390/biomedicines4030018)	ORCID	43.90	56
50	Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy… (10.3390/biomedicines5010008)	ORCID	43.90	56